Loading clinical trials...

COMPLETEDNA

ED-Home Pilot Study

ED-Home: A Pilot Feasibility Study of a Homelessness Prevention Intervention for Substance Using Emergency Department Patients

NCT03864341•NYU Langone Health

View on ClinicalTrials.gov

Summary

This is a single-arm pilot study to test the feasibility of homelessness prevention and substance use interventions to be delivered to at-risk patients in the Bellevue Hospital emergency department (ED). ED patients (n=40) found eligible for the study will complete a baseline assessment and receive referrals to appropriate services, with a final six-month follow-up assessment.

Detailed Description

ED patients found eligible for the study will complete a baseline survey and receive one-time, in person services at the time of the baseline/enrollment ED visit including referrals to homelessness prevention and substance use services, with a final six-month follow-up survey. Interim contacts at 7-10 days, 3 months, and 5 months will be used to assure intervention components were received and to confirm participant contact information.

Eligibility

Age

18 - 99 years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Be a patient in the Bellevue Hospital Center ED.
•Be ≥18 years old.
•Screen positive for homelessness risk using a homelessness risk screening tool (HRST).
•Screen positive for unhealthy alcohol or drug use.
•Able to provide consent.

Exclusion Criteria

•Medically (e.g., critically ill) or psychiatrically unstable.
•Unable to provide informed consent for other reason (e.g., cognitive deficit, profound intoxication).
•Incarcerated or in police custody.
•Unable to understand and speak English.
•Lives outside NYC and/or cannot give a NYC ZIP code.
•Already homeless (residing in a shelter or on the streets).
•Does not have a telephone where can be reached for follow-up.
•Has already received specialized peer navigator/addiction social worker services during current ED visit.
•Has already participated in the study.

Locations (1)

New York University School of Medicine

New York, New York, United States

Key Dates

Start Date

May 8, 2019

Primary Completion Date

March 23, 2020

Completion Date

March 23, 2020

Last Updated

August 19, 2022

Enrollment

ACTUAL participants

Conditions

Housing ProblemsDrug UseAlcohol; Use, Problem

Interventions

Referral to homelessness prevention services

BEHAVIORAL

Substance use services

BEHAVIORAL

Follow-up

BEHAVIORAL

Long-acting Cabotegravir Injectable Pre-exposure Prophylaxis for People Who Inject Drugs

NCT07199335

HIVSubstance Use Disorder (SUD)+1 more

View study

RECRUITINGPHASE4

Implementing Low-Barrier HCV Treatment in a Jail Setting

NCT06953479

HEPATITIS C (HCV)Incarceration+2 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: August 19, 2022Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

ED-Home Pilot Study

Inclusion Criteria

Exclusion Criteria

Long-acting Cabotegravir Injectable Pre-exposure Prophylaxis for People Who Inject Drugs

Implementing Low-Barrier HCV Treatment in a Jail Setting

Effectiveness of ACT for Problematic Chemsex

Assessment of Metformin for Restoration of Immune Homeostasis in HIV+ and HIV- Individuals With a History of Injection Drug Use

Project Khanya: Peer-Delivered Intervention to Improve HIV Medication Adherence and Substance Use in South Africa

Addressing Barriers to Care for Substance Use Disorder Pilot Study